Genomics into health
As genomic experts, we have a comprehensive understanding of how innovative technologies can contribute to more effective healthcare
We work with policy-makers, clinicians, academia and industry to develop future-focused healthcare strategies for safe and suitable use of innovations, such as diagnostics, genome editing and regenerative medicines. Only through understanding the benefits - and complexities - of genomics-based innovations and other 'omics sciences can we help everyone benefit from great science.
Report Control of patient information in the COVID-19 era
The control of patient information (COPI) notices have had significant positive impacts on COVID-19 - related research, but the success of future reforms to the use of CPI relies on building trustworthiness.
Policy briefing CAR-T cell therapies
CAR-T cell therapies are a form of cellular immunotherapy that use genetically modified T cells, a type of white blood cell.
Blog Genome UK: new four nations commitments to priority actions
18 March 2022
New commitments for UK-wide implementation of genomics have been announced that aim to accelerate research and drive healthcare innovation.
Blog Using genomics to improve drug prescribing
4 April 2022
A recent joint report has outlined guidance, barriers and opportunities around the use of pharmacogenomics.
Report Our healthy future
What do we want our healthy future to look like, and how can we ensure science helps our path towards that future?
Briefing Antisense oligonucleotide therapies
3 September 2021
Policy briefing on ASOs and their RNA molecule targeting
16 August 2021
What is pharmacogenomics?
Explainer Nutritional genomics
29 July 2021
Nutrients in our diet affect how our bodies function and our overall health.
Explainer Microbiome analysis and manipulation
27 July 2021
A short overview of the potential healthcare uses of understanding the microbiome
Explainer What is stem cell therapy?
8 July 2021
A short overview of stem cell therapy
Blog Expanding the public and patient role in medical regulation
6 July 2021
A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI).
Blog Putting Genome UK into practice
18 May 2021